Melissa Nott DavisPartnerMcDermott Will & Emery Websitewww.mwe.comBlogwww.mwe.com/insightsConnectEmailTwitterLinkedIn617-535-4189 Professional Biography Melissa Nott Davis is a partner in the law firm of McDermott Will & Emery LLP and is based in the Firm’s Boston office. More Legal and Business Bylines From Melissa Nott Davis Concerted Actions with Sister Company in Finland Result in Delaware Jurisdiction - (Posted On Monday, August 29, 2016) Rosebud LMS Inc. v. Adobe Systems Inc.: Pre-Issuance Damages Possible Only If You “Know” About the Published Application - (Posted On Wednesday, March 30, 2016) Attorneys’ Fee Award Cannot Be Enhanced to Deter Misconduct - (Posted On Thursday, February 25, 2016) There Is More than One Way to Slice the Apportionment Analysis re: Patent litigation - (Posted On Thursday, January 28, 2016) Apple Secures Its Permanent Injunction in Apple v. Samsung Electronics - (Posted On Monday, November 02, 2015) A Primer on Patent Damages: Carnegie Mellon University v. Marvell Technology Group, Ltd., et al. - (Posted On Wednesday, September 30, 2015) A Joint Author Does Not Own Derived Material - (Posted On Thursday, August 27, 2015) Arborjet, Inc. v. Rainbow Treecare Scientific Advancements, Inc.: Proof of Confusion Essential for Trademark Injunction - (Posted On Thursday, August 27, 2015) Applicability of the Entire Market Value Rule in Hatch-Waxman Cases - (Posted On Sunday, May 31, 2015) Lost Profits Are Hard to Come By: Warsaw Orthopedic v. NuVasive Patent Litigation - (Posted On Saturday, May 02, 2015) Pagination Page 1 Next page Next › Current Legal Analysis District Court Holds Pension Fund Misapplied Prior Partial Withdrawal Liability Credit by: Neil V. Shah , Sydney L. Juliano FDA Announces Expanded Use of Unannounced Inspections at Foreign Manufacturing Facilities by: Food and Drug Law at Keller and Heckman No Protectable Code: No Literal or Nonliteral Copying by: Keval Amin FDA and NIH Launch Joint Nutrition Regulatory Science Program by: Food and Drug Law at Keller and Heckman Up in Smoke: Statutory Trademark Damages Can Exceed Actual Damages by: Taylor MacDonald FDA Extends Comment Period for Front-of-Package Nutrition Labeling Rule by: Food and Drug Law at Keller and Heckman U.S. State PFAS Initiatives — A Conversation with Richard E. Engler, Ph.D. and Carla N. Hutton [Podcast] by: Lynn L. Bergeson FDA Releases 2023 CORE Annual Report by: Food and Drug Law at Keller and Heckman Complaint Need Not Allege Fraud, Misrepresentation, Or Deceit To Be "Based Upon" A Corporation’s “Fraud, Misrepresentation or Deceit" by: Keith Paul Bishop FDA to Rehire Some Staff by: Food and Drug Law at Keller and Heckman BIS Issues Four Key Updates on Advanced Computing and AI Export Controls by: Anthony Rapa , Alan Kashdan Proposed System to Define Ultra-Processed Foods by: Food and Drug Law at Keller and Heckman ANOTHER SLICE OF THE PIE: Serial TCPA Plaintiff Goes After Pizza Hut by: Tammana Malik FCA’s Discretion Upheld in IRHP Redress Scheme Judicial Review by: Chris Webber Changes to EEO-1 Report Approved by: Laura A. Mitchell Upcoming Events May 22 2025 Kidd Aitken & Chambers USA Q&A May 15 2025 L&E Global Immigration Webinar Series | Strategic Expansion of U.S. Companies in Portugal and Spain: Setting Up Branches and Immigration Pathway May 15 2025 Using Extrinsic Evidence to Determine the Duty to Defend: Eight Corners, Four Corners, or No Corners? May 15 2025 Discovering Weaknesses; Protecting Work Product; Coordinating With Expert Discovery Print
